 |
市场调查报告书
商品编码
1190254
细胞培养基袋市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)Cell Culture Media Bags Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计在预测期内（2022 年至 2027 年），细胞培养基袋市场的复合年增长率为 10%。
由于疫苗接种需求增加，预计 COVID-19 的爆发将对细胞培养基袋市场产生重大影响。 细胞培养基袋在疫苗接种和蛋白质药物生产中发挥着重要作用。 细胞培养基袋在候选疫苗的研发和测试过程中被广泛使用。 根据《计算与结构生物技术杂誌》2021 年发表的一篇论文，有 184 种候选疫苗处于临床前试验阶段，88 种其他候选疫苗处于临床阶段。 因此，COVID-19 大流行对细胞培养袋市场产生了积极影响，并促进了其增长。
生物製药领域研发活动的增加预计将推动市场增长。 根据印度品牌资产基金会的数据，印度在 2020 年拥有超过 2,700 家生物技术初创公司，预计到 2024 年将达到 10,000 家。 Seed Scientific 还宣布，到 2021 年，将有超过 6,600 家生物技术公司活跃在美国的研发活动中。 细胞培养基袋通过提供生物製药开发所需的适当营养物质来促进靶细胞生长。 此类细胞培养袋的显着优势增加了生物製药对细胞培养基的扩增、储存和浓缩的需求。 因此，对生物製药不断增长的需求正在推动细胞培养袋市场的增长。 它还广泛用于干细胞和肿瘤学研究，因为它提供了支持靶细胞生命週期的人工环境。 全球人口中癌症患病率的上升以及对开创性治疗的需求不断增加预计将推动市场增长。 根据全球癌症观察站的数据，2021 年全球将有约 120 万年轻人被诊断出患有癌症。 越来越多的癌症患者需要有效的治疗方案，并增加了对细胞培养液袋的需求，因为它们在癌细胞研究中被广泛采用。 这是因为细胞培养袋的设计目的是将采购的细胞分开，并通过防止暴露于外部环境来完成气密密封，从而可以研究癌细胞的行为和肿瘤细胞的生长情况，有助于设计治疗方法。
人口老龄化等因素更容易患上慢性病和疾病，这推动了对生物製药的需求，导致製造商越来越多地使用细胞培养基袋。 根据美国疾病控制和预防中心 (CDC) 的数据，到 2020 年，大约 85% 的老年人将患有至少一种慢性疾病，而 60% 的老年人将患有至少两种。。 因此，老年人口的增加以及对生物製药需求的增加预计将推动市场的增长。
细胞培养中袋市场趋势
2D 细分市场有望主导市场份额
COVID-19 的突然爆发增加了对用于治疗和接种感染者的生物製药的需求。 此外，二维设计中袋预计在预测期内将占据很大份额，例如用于新药开发和使用细胞的研究。
由于细胞培养基袋越来越多地用于生物製药行业的产品开发，因此二维设计的细胞培养基袋有望占据主要市场份额。 需求的增加是由于全球抗击癌症等新兴疾病的研发活动增加。 介质袋还可以通过减少灭菌和清洁步骤来降低生产成本。 其他优点包括重量轻、高阻隔和减少污染情况，二维设计的细胞培养袋适用于生物製药行业。
此外，生物製药行业在新疗法研发方面的支出增加等主要因素预计将对市场增长产生重大影响。 根据经济合作与发展组织（OECD）2020年公布的数据，OECD国家製药行业在研发方面的支出约为1010亿美元。 同一消息来源还报导说，全球最大的上市公司的研发支出每年增长 13.7%。 因此，生物製药行业增加研发支出以开发其产品线有望推动市场研究领域的增长。 因此，细胞培养基袋的二维设计有望占据主要市场份额。
预计北美将占据很大的市场份额，预计在预测期内也是如此。
在美国地区，不断专注于开发新的先进疗法的製药和生物技术行业的繁荣是市场增长的主要因素之一。 根据美国研究组织的数据，2020 年美国用于开发新疗法的医疗卫生研发达到 2541 亿美元，占总支出的 67%。 市场增长也受到该地区早期采用基因表达和疫苗等技术进步的推动。 此外，寻求有效治疗的人群中越来越多的慢性病患者增加了该地区对细胞培养基袋的需求。 例如，正如美国疾病控制与预防中心 (CDC) 在 2021 年宣布的那样，每 10 个美国人中就有 6 个患有至少一种慢性疾病，例如心脏病或癌症。 因此，对新型疗法的需求不断增加，导致细胞培养基袋的使用量增加，从而推动了该地区的市场增长。 此外，该地区主要市场参与者的存在也是该地区市场增长的主要因素。
细胞培养基袋市场竞争分析
细胞培养基袋市场是分散的，由几家主要参与者组成。 从市场份额的角度来看，一些主要参与者目前主导着市场。 目前主导市场的公司包括 Thermo Fisher Scientific、Sartorius AG、Corning Incorporated、Danaher、Fukoku、OriGen Biomedical、Lonza、Saint-Gobain Performance Plastics、Shanghai LePure Biotech、Technoflex 等。
其他福利。
- Excel 格式的市场预测 (ME) 表
- 3 个月的分析师支持
内容
第一章介绍
- 研究假设和市场定义
- 调查范围
第二章研究方法论
第 3 章执行摘要
第四章市场动态
- 市场概览
- 市场驱动因素
- 提高生物製药、肿瘤学和干细胞研究的增长潜力
- 老年人口增加
- 市场製约因素
- 污染和废物处理的可能性增加
- 波特的五力分析
- 新进入者的威胁
- 买方/消费者议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争公司之间的敌对关係
第 5 章市场细分
- 设计
- 二维
- 3D
- 按地区
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 其他欧洲地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东和非洲
- 海湾合作委员会
- 南非
- 其他中东和非洲地区
- 南美洲地区
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第六章竞争格局
- 公司简介
- Thermo Fischer Scientific
- Sartorius AG
- Corning Incorporated
- Danaher
- Fukoku Co. Ltd
- OriGen Biomedical
- Lonza
- Saint-Gobain Performance Plastics
- Shanghai LePure Biotech Co. Ltd
- Technoflex
第7章 市场机会今后动向
The cell culture media bags market is projected to register a CAGR of 10% during the forecast period (2022-2027).
The COVID-19 outbreak is expected to have a significant impact on the cell culture media bags market due to the increasing demand for vaccination. The cell culture media bags play a crucial role in the production of vaccination and protein-based drug. The cell culture media bags are extensively used in the developmental phases and trial process of vaccine candidates. According to the article published by the Computational and Structural Biotechnology Journal in 2021, there are 184 vaccine candidates in pre-clinical testing and other 88 vaccine candidates in clinical phases. Thus, the COVID-19 pandemic has impacted the cell culture media bags market positively and contributed to its growth.
The increasing R&D activities in the biopharmaceutical sectors are expected to drive the growth of the market. According to the India Brand Equity Foundation, in 2020, there were more than 2700 biotech startups in India, which is estimated to reach 10,000 by 2024. Also, Seed Scientific Published in 2021 that over 6,600 biotech companies operate in United States with active research and development activities. Cell culture media bags allow the growth of the target cells by providing suitable nutrients required for the development of biopharmaceuticals. This remarkable advantage of cell culture bags increased their demand in biopharmaceuticals for the expansion, storage, and concentration of cell culture mediums. Thus, the rising demand for biopharmaceuticals drives the growth of the cell culture media bags market. They are also extensively used in stem cell research and oncological studies as they provide an artificial environment that aids the life cycle of the target cells. The rising prevalence of cancer among the global population and the increasing necessity for the development of treatment are expected to drive the growth of the market. According to the Global Cancer Observatory, in 2021, around 1.2 million young adults were diagnosed with cancer across the world. Such increasing cancer cases demand effective treatment therapies, which increases the demand for cell culture media bags as they are widely employed in the study of cancer cells. This is due to cell culture bags being designed to isolate the procured cells and complete sealing by preventing exposure to the outside environment, which helps study the behavior of cancer cells and design a treatment for tumor cells.
Factors like the increasing geriatric population that is prone to chronic conditions and diseases drive the demand for biopharmaceuticals, resulting in the increasing usage of cell culture media bags by manufacturers. According to the Centers for Disease Control and Prevention (CDC), in 2020, approximately 85% of older adults had at least one chronic health condition, and 60% had at least two chronic conditions. Therefore, the increasing geriatric population, coupled with the rising demand for biopharmaceuticals, is expected to drive the growth of the market.
Cell Culture Media Bags Market Trends
The 2D Segment is Expected to Hold a Major Market Share
The sudden outbreak of COVID-19 had increased the demand for biologics to treat the infected people and provide vaccinations. The 2D design of the cell culture media bags segment is expected to hold the major share in the forecast period owing to the novel drug development and cell-based studies.
2D design cell culture media bags are expected to hold the major share in the market due to the increasing usage of cell culture media bags in the biopharmaceutical industries for their product development. The increasing demand is due to the increase in research and development activities to conquer emerging diseases, such as cancer, across the world. Also, cell culture media bags reduce the cost of production by decreasing the sterilization and cleaning processes. Additionally, the benefits offered by 2D design cell culture bags such as lightweight, high barrier, and decreased contamination cases make them more suitable for the biopharmaceutical industry.
Also, key factors such as increasing expenditure in the research and development by biopharmaceutical industries to novel treatments are expected to have a significant impact on the growth of the market. According to data published by the Organisation for Economic Co-Operation and Development (OECD) in 2020, the pharmaceutical industry spent nearly USD 101 billion on research and development in the OECD countries. Also, from the same source, it is reported that global R&D spending by the largest publicly- traded companies grew by 13.7% annually. Therefore, the increasing expenditure on research and development by the biopharmaceutical industry to develop their product pipelines is expected to boost the growth of the studied segment in the market. Hence, the 2D design of cell culture media bags is expected to hold the major market share.
North America is Expected to Hold a Significant Share in the Market, and It is Expected to do the Same During the Forecast Period
The flourishing presence of pharmaceutical and biotechnology industries, which are constantly focusing on the development of new and advanced therapies in the US region, is one of the major factors for the market growth. According to the Research America Organization in 2020, US medical and health R&D reached USD 254.1 billion for the development of novel treatments, which is 67% of the total spending. Also, the quick adoption of technological advancements in gene expression, vaccines, etc., in this region is also a contributing factor to the growth of the market. Also, factors such as the rising prevalence of chronic disorders among people demanding effective therapies and treatments also increased the demand for cell culture media bags in this region. For instance, six in ten Americans live with at least one chronic condition such as heart disease, cancer, etc., as published by the Centers for Disease Control and Prevention (CDC) in 2021. Thus, the increase in demand for novel treatment therapies, contributing to the increasing usage of cell culture media bags, is driving the growth of the market in this region. Additionally, the presence of major market players in this region is also a major factor in the growth of the market in this region.
Cell Culture Media Bags Market Competitive Analysis
The cell culture media bags market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies currently dominating the market are Thermo Fisher Scientific, Sartorius AG, Corning Incorporated, Danaher, Fukoku Co. Ltd, OriGen Biomedical, Lonza, Saint Gobain Performance Plastics, Shanghai LePure Biotech Co. Ltd, Technoflex, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Increasing Growth in Biopharmaceuticals, Oncology, and Stem Cell Research
- 4.2.2 Increasing Geriatric Population
- 4.3 Market Restraints
- 4.3.1 Increased Possibility of Contamination and Waste Disposal
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
- 5.1 Design
- 5.1.1 2D
- 5.1.2 3D
- 5.2 Geography
- 5.2.1 North America
- 5.2.1.1 United States
- 5.2.1.2 Canada
- 5.2.1.3 Mexico
- 5.2.2 Europe
- 5.2.2.1 Germany
- 5.2.2.2 United Kingdom
- 5.2.2.3 France
- 5.2.2.4 Italy
- 5.2.2.5 Spain
- 5.2.2.6 Rest of Europe
- 5.2.3 Asia-Pacific
- 5.2.3.1 China
- 5.2.3.2 Japan
- 5.2.3.3 India
- 5.2.3.4 Australia
- 5.2.3.5 South Korea
- 5.2.3.6 Rest of Asia-Pacific
- 5.2.4 Middle-East and Africa
- 5.2.4.1 GCC
- 5.2.4.2 South Africa
- 5.2.4.3 Rest of Middle-East and Africa
- 5.2.5 South America
- 5.2.5.1 Brazil
- 5.2.5.2 Argentina
- 5.2.5.3 Rest of South America
- 5.2.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Thermo Fischer Scientific
- 6.1.2 Sartorius AG
- 6.1.3 Corning Incorporated
- 6.1.4 Danaher
- 6.1.5 Fukoku Co. Ltd
- 6.1.6 OriGen Biomedical
- 6.1.7 Lonza
- 6.1.8 Saint- Gobain Performance Plastics
- 6.1.9 Shanghai LePure Biotech Co. Ltd
- 6.1.10 Technoflex
